Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-15-000049
Filing Date
2015-06-08
Accepted
2015-06-08 16:04:18
Documents
3
Effectiveness Date
2015-06-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2015.htm DEFA14A 33690
2 caladriuslogoa01.jpg GRAPHIC 333151
3 dmazzosignature.jpg GRAPHIC 9186
  Complete submission text file 0000320017-15-000049.txt   506951
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 15918532
SIC: 8090 Services-Misc Health & Allied Services, NEC